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Abstract Endophenotypes or intermediate phenotypes are of
great interest in neuropsychiatric genetics because of their
potential for facilitating gene discovery. We evaluated response
inhibition, latency and variability measures derived from the
stop task as endophenotypes of ADHD by testing whether they
were related to ADHD traits in the general population, heritable
and shared genetic risk with ADHD traits. Participants were
16,099 children and adolescents, ages 6 to 18 years who visited
a local science center. We measured ADHD traits using the
Strengths and Weaknesses of ADHD-symptoms and Normal-
Behavior (SWAN) rating scale and performance on the stop
signal task (SST)—response inhibition (SSRT), response laten-
cy (GoRT), and response variability (GoRTSD). Regression
analysis was used to assess the relationship of cognitive meas-
ures and ADHD traits while controlling for family, age, sex,
ethnicity, socioeconomic status and treatment status. Heritabil-
ity of ADHD and cognitive traits was estimated using SOLAR
in 7,483 siblings from 3,507 families that included multiple
siblings. Bivariate relationships between pairs of variables were
examined. Individuals with greater ADHD trait scores had
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worse response inhibition, slower response latency, and greater
variability. Younger participants and girls had inferior perfor-
mance although the gender effects were minimal and evident in
youngest participants. Inhibition, latency, variability, total
ADHD traits, inattention and hyperactivity-impulsivity scores
were significantly heritable. ADHD traits and inhibition, but
not latency or variability were coheritable. In the largest study
in the general population, we found support for the validity of
response inhibition as an endophenotype of ADHD.
Keywords ADHD . Stop signal task . General population .
Endophenotype . Heritability
Attention deficit hyperactivity disorder (ADHD) is a complex
disorder characterized by extremes of inattention, hyperactiv-
ity and impulsivity, by clinical and genetic heterogeneity and
by high heritability whether it is measured as a discrete diag-
nostic entity or as a continuous trait in the general population
(Swanson et al. 2009; Thapar et al. 2007). Despite high
heritability, no gene conferring large relative risk has been
identified. Meta-analyses of ADHD linkage studies supports
genome-wide significance on 16q21-16q24 (Zhou et al. 2008)
but the largest and most comprehensive genome-wide associ-
ation study did not identify any genome-wide significant
findings (Franke et al. 2009; Neale et al. 2010). Identification
of the genetic contributions to the disorder is complicated by
phenotypic and genetic heterogeneity, low penetrance and low
statistical power of existing studies (van der Sluis et al. 2010).
One way to enhance the power of genetic discovery is to
reduce clinical and genetic heterogeneity by use of endophe-
notypes (Kendler and Neale 2010). Endophenotypes are bio-
logical traits that mediate the association between some of the
genetic risks for a disease and the disease phenotype and
which have a genetic architecture that is less complex than
that of the disorder itself (Crosbie et al. 2008; Gottesman and
Gould 2003; Szatmari et al. 2007). Potentially useful endo-
phenotypes are those that are associated with the disorder,
evident in relatives because of their increased genetic risk,
heritable and share genetic risk with the disease phenotype
(Crosbie et al. 2008; Gottesman and Gould 2003; Kendler and
Neale 2010).
Considerable research into ADHD endophenotypes has fo-
cused on executive function processes that are involved in
planning, decision making and action. Among the most exten-
sively studied candidate endophenotypes are motor response
inhibition, response latency and response variability (Frazier-
Wood et al. 2012). Meta-analysis indicates that patients with a
diagnosis of ADHD have deficient inhibitory control compared
with controls with a medium effect size of 0.63 (Lipszyc and
Schachar 2010) and that inhibitory control is worse in non-
ADHD siblings and in parents of ADHD probands than it is in
normally developing individuals (Goos et al. 2009; Schachar et
al. 2005). Twin studies indicate that inhibitory control is heri-
table (Friedman et al. 2008; Schachar et al. 2011). Several risk
alleles are associated with poor inhibition (Bellgrove and
Mattingley 2008; Langley et al. 2004; Swanson et al. 2000)
and with brain activity associated with response inhibition
(Barnes et al. 2011; Cummins et al. 2011). Response speed
and variability reflect consistency of attention and effort. Meta-
analysis shows a small-to-medium effect size for response
latency and a medium effect size for variability (0.71) (Lipszyc
and Schachar 2010; Sergeant 2000) in distinguishing individ-
uals with and without an ADHD diagnosis. Twin studies have
found that response variability was heritable (Frazier-Wood et
al. 2012; Friedman et al. 2008; Young et al. 2009).
Endophenotypes derived from simple laboratory tests such
as the SST have the potential advantage of being suitable for
general population research where they could help identify
individuals at genetic risk for disorder without a time-
consuming and costly diagnostic assessment. Despite this po-
tential utility, there has been little research of validity of can-
didate endophenotypes in the general population (c.f. Cornish
et al. 2005). In this study, we use the stop signal task (SST)
(Logan et al. 1997; Verbruggen and Logan 2009a) to investi-
gate the relationship of response inhibition, latency and vari-
ability and ADHD traits in the general population. If response
inhibition, latency and variability are genetically informative
endophenotypes, they should be correlated with ADHD traits
even after controlling for age, gender, socioeconomic status and
ethnicity. They should also be heritable and share genetic risk
with ADHD traits. We investigated these questions using the
SST and the Strengths and Weaknesses of ADHD-symptoms
and Normal-Behavior (SWAN) rating scale as a measure of
ADHD traits. In related individuals, we used Sequential Oligo-
genic Linkage Analysis Routines (SOLAR) to estimate herita-
bility of individual traits and shared genetic risk of pairs of traits.
Method
Participants
We evaluated 16,099 individuals, 6 to 18 years of age, at the
Ontario Science Centre (OSC) in Toronto, Canada (http://
www.ontariosciencecentre.ca). The OSC has about one mil-
lion visitors each year of all ages, social backgrounds and
ethnic groups and is a leading developer of interactive exhi-
bitions for science centres around the world. Participants were
tested at workstations with dividers in a specifically designed
exhibition on genes, brain and behaviour. Visitors that showed
interest in the display were invited to participate. Typically,
there are several such participatory research studies going on
at the Science Centre at any one time as part of the mission of
the Centre. Participants were individually supervised during
testing by undergraduate university students.
498 J Abnorm Child Psychol (2013) 41:497–507
Parents provided consent and SWAN ratings for children
ages 6–12 while children completed the SST. Individuals
aged 13–18 provided consent and self-report SWAN ratings
before completing the SST. Participants provided a saliva
sample for genetic analyses. The study was approved by The
Hospital for Sick Children’s research ethics board. Testing
was restricted to 30 min. No compensation was given to
participants.
Socioeconomic status as measured by household income
was estimated from postal codes referenced against 2006
Canadian national census data, which provides size-adjusted
household income for neighbourhoods (Wilkins 2009). Eth-
nicity was estimated using a self-report questionnaire and
participants were classified as Caucasian if four grandpar-
ents were Caucasian. Caucasians made up the majority of
cases; the remainder were coded as non-Caucasian for the
purpose of this study (although detailed ethnicity information
was available). There were 991 participants who reported a
prior diagnosis of ADHD (6.2 %) of which 395 reported
taking ADHD medication within the previous 2 days and 19
who didn’t report a diagnosis of ADHD but did report taking
ADHD medication (0.1 %).
ADHD Trait Measure
The SWAN is based on the 18 ADHD items in the DSM-IV
(American Psychiatric Association 1994; Swanson et al.
2001). Items are worded to capture both strengths and
weaknesses on a seven point scale (+30far above average
indicating a strength in a particular trait or low ADHD trait
scores, to −30far below average indicating the presence of
an ADHD trait) (Swanson et al. 2001). Scores for the nine
inattention and for the nine hyperactivity-impulsivity trait
items were also calculated. There is a high correlation be-
tween Conners Parent and Teacher Rating Scales (Conners
1998) and SWAN ratings of approximately 0.90 for teacher
ratings and 0.80 for parent ratings (Cornish et al. 2005) and
there is high agreement on which individuals were in
the extremes of the distribution on these two measures
(Polderman et al. 2007). For clarity of interpretation and
discussion, SWAN scores were reversed in the analyses such
that higher SWAN scores represented higher ADHD traits.
The paper will refer to these scores as high or low ADHD
traits; when actual values are presented, positive values
represented greater ADHD traits (+54 indicating the highest
possible ADHD trait score, and −54 representing the lowest
possible ADHD trait score).
Stop Signal Task
Response inhibition, latency and response variability were
measured using the SST (Logan et al. 1997). The SST
consists of two concurrent tasks—a go and a stop task.
The go task is the presentation of one of two letters (an X
or an O) on each trial. Participants were required to make a
response to the go task stimuli as quickly and as accurately
as possible by pressing one key of a hand held game pad for
an X and the other for an O. The stop task involved an
auditory signal which was presented, at random, on 25 % of
trials. The stop signal instructed participants to withhold
their response on that particular trial. The stop tone was a
1,000 Hz tone emitted by the computer and presented by
headphones at a comfortable listening level. The task con-
sisted of a practice block (24 trials; 18 go trials; six stop
trials) and four experimental blocks of 24 trials for a total of
72 go trials and 24 stop trials. Each trial began with a fixate
stimulus which was presented for 500 ms followed by the
go-signal (X or O) which was presented for 1,000 ms. The
total trial duration was 3,500 ms allowing 3,000 ms for a go
task response. The task paused briefly after each block so
that the supervisor could check if there were any error
messages indicating that the participant was not following
task instructions.
Performance in the stop signal task can be modeled as a
race between two independent processes—the response ex-
ecution process initiated by the presentation of the go signal
and finishing with the motor response and the stop process
initiated by the presentation of the stop signal (Verbruggen
and Logan 2009b). If the stop process finishes before the go
process, the response is stopped. If the go process finishes
before the stop process, the response is executed just as if no
stop signal were presented. The outcome of the race and the
probability of stopping a particular response depend on the
speed of go response and the speed of the internally gener-
ated stopping process the latency of which is known as stop
signal reaction time (SSRT). The outcome of the race also
depends on the delay between the onset of the go and the
onset of the stop processes. Delay is under experimental
control. Stop signal delay, initially set at 250 ms, was
dynamically adjusted depending on performance. If partic-
ipants were able to stop on a particular trial, the delay was
increased by 50 ms in order to make it more difficult to stop
on the next trial. If they were unable to stop, the delay was
shortened by 50 ms (Logan et al. 1997). Go reaction time
and variability is evident in the latency of trials that do not
involve a stop signal. The primary dependent variable,
SSRT can be estimated by subtracting mean delay from
mean go response time on no-signal trials when the partic-
ipant’s probability of stopping is approximately 0.50. With
departures from probability of inhibition given a stop signal
from 0.50, SSRT can be calculated through an integration
procedure as was done in the current study. Go reaction times
in which no stop signal were presented were rank ordered and
the go reaction time that corresponded to the probability of
inhibition was determined. For example, if a participant
inhibited 60 % of their go responses, one finds the 60th
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slowest go reaction time. All slower go responses would have
been stopped; all faster ones would have been executed.
Interpolated SSRT is estimated by subtracting mean delay
from the integrated go reaction time (Verbruggen and Logan
2009a) and is the primary dependent variable in this study.
Participants (970) were excluded if they performed the
task in an invalid manner (go task with less than 66 %
accuracy, mean GoRT of less than 100 ms indicating that
they were guessing on the go trials, or inhibited on more
than 80 % or fewer than 20 % of stop signal trials). As
an added check, we recalculated all models on partici-
pants who inhibited more than 0.40 or less than 0.60
(95 % confidence interval for probability of inhibition of
0.50). We present models for the entire sample because
results were not affected by this additional set of exclu-
sion criteria. Participants (147) were also excluded if they
interrupted the task before completion because of time con-
straints on their family visit to the Science Centre or pushed
the wrong buttons on the game pad device used to collect
responses (180).
Analyses
Regression analysis was conducted to identify the best com-
bination of variables making a unique contribution to SSRT,
GoRT and GoRTSD while considering family as a random
effect (Singer 1998). In order to normalize the residuals
from each model, we modeled the log of the stop task
variables. Because of the high correlation of latency and
variability, we calculated a new variable, GoRTSD/GoRT.
However, the distribution of the residuals violated the
assumptions of the model and no transformation of the
derived variable improved the result. Therefore, we chose
to control GoRT in models of GoRTSD by entering GoRT
into regression models. Models included gender, ADHD
traits and age which were added using a forward stepwise
approach. The higher order terms, age*age, gender*age,
age*age*gender were also assessed when main effects were
significant. We plotted predicted values obtained from mod-
els with and without the higher order terms in order to
compare the predicted values between the simpler and more
complex models to assess the clinical significance of the
higher order terms.
In order to evaluate the effect of age, gender, and ADHD
trait on the stop task values, we calculated an approximation
of Cohen’s effect size using the equation
pred1 pred2ð Þ sqrt stderrpred1^2þ stderrpred2^2ð Þ=
where stderrpred1 and stderrpred2 are the standard devia-
tions of a single observation as obtained from the regression
model. Effect sizes were calculated for specific scenarios,
such as the effect of gender at age 6 in children with a Swan
score of 54.
To determine if extremely low SWAN scores might also
be maladaptive, we compared participants with high, medi-
um and low SWAN scores on rates of parent-reported
ADHD, anxiety, depression, learning disability and other
disorders.
We estimated SSRT for 414 (2.6 %) participants who
reported taking medication for ADHD within 48 h of testing
by adjusting SSRT by 0.75 effect size based on the results of
published studies of the effect of a moderate dose of stim-
ulant medication on SST performance (Tannock et al. 1995).
Results did not differ when analyses were conducted with
and without these participants; consequently they were ex-
cluded from the subsequent analyses. The final sample
(14,388) consisted of 7,176 boys (49.9 %) and 7,212 girls
(50.1 %).
Heritability of each SST variable and of ADHD traits
with age and sex as covariates was estimated using SOLAR
(Almasy and Blangero 1998) in the subset of 3,507 families
that included multiple full siblings (7,483). Of these fami-
lies, 3,081 were from families with two children or adoles-
cents, 387 with 3, 35 with 4, and 4 with 5. SOLAR
decomposes the total variance of the phenotype into com-
ponents that are the result of genetic effects (i.e. polygenic,
additive genetic variance), measured covariates and random
environmental effects (i.e. measured environmental factors
and random unmeasured factors). The relative contribution
of genetic factors to each trait is then estimated by herita-
bility (h2): the ratio of the genetic variance component to the
residual (after removal of variance explained by covariates)
phenotypic variance. We calculated confidence intervals for
heritability estimates under the asymptotic normality as-
sumption of the Maximum Likelihood estimator where sam-
ple size is~7,000 using the formula
100 1 að Þ% asymptotic confidence intervals
h2  Z a 2=ð ÞSE; h2 þ Z a 2=ð ÞSE 
(Neale and Miller 1997).
Bivariate analyses were conducted on pairs of neuropsy-
chological measures that demonstrated significant univariate
heritability to partition the phenotypic correlation between
two traits (RhoP) into genetic (Rhog) and environmental
(Rhoe) correlations according to the equation
RhoP ¼ Rhog
ﬃﬃﬃﬃﬃ
h21
q ﬃﬃﬃﬃﬃ
h22
q
þ Rhoe
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 h21
 q ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 h22
 q
where h1
2 and h2
2 correspond to heritabilities of traits 1 and 2,
respectively. Evidence of pleiotropy (a common set of genetic
influences affecting more than one trait) is indicated by a
genetic correlation significantly different from zero (Rhog0
0: no shared gene effect; Rhog01 or –1: complete pleiotropy).
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We estimated heritability of SST variables with and without
SWAN ADHD traits as covariates in order to control for the
influences of ADHD traits on cognitive performance. Herita-
bility estimates were essentially unchanged and are presented
with ADHD controlled.
Results
Sample Characteristics
Table 1 presents mean SWAN scores for ADHD traits, age,
sex and ethnicity for the final study sample (N014,388) and
for 1,711 cases who were excluded because they had taken
medication prior to participation (414) or who had invalid or
incomplete performance the SST (1297). Compared with
included cases, excluded cases had significantly higher
(i.e. more severe) ADHD traits and were more often youn-
ger males, but did not differ in ethnicity or socioeconomic
status. Half of the sample was Caucasian. Figure 1 shows a
scatterplot of response inhibition and ADHD traits. Figure 2
shows the distribution of ADHD traits in the sample. The final
sample had a mean SSRT of 304.4 ms (SD0145.6), GoRT of
599.3 ms (SD0111.1) and GoRTSD of 158.7 ms (SD055.6).
There was a bias toward more economically privileged
participants. Approximately 16 % of study participants were
from the poorest neighbourhoods compared with 37 % in
the surrounding metropolitan area, whereas 25 % of partic-
ipants were from the richest neighbourhoods compared with
16 % in the surrounding area. Neither ethnicity nor socio-
economic status had a significant effect on the ADHD traits
or SST variables or interactions and are not considered
further. Rates of reported psychiatric disorder were lowest
for individuals with lowest ADHD trait scores and increased
with increasing ADHD trait scores suggesting that extreme-
ly low scores were not maladaptive (data available).
Stop Signal Task Performance and Trait-ADHD
Supplementary Figures 1–3 show the distribution of SSRT,
GoRT and GoRTSD prior to transformation. Q-Q plots for
the models after transformation (Supplementary Figures 4–6)
showed approximately normally distributed residuals indi-
cating that the models were correctly specified, there was
generally good model fit and the models were not highly
influenced by outliers.
Gender (p00.0002), ADHD traits (p<0.0001), age (p<
0.0001), age*gender (p00.02) and age*age (p<0.0001)
were significantly associated with SSRT scores. Children
with higher ADHD trait scores had longer SSRT represent-
ing inferior inhibition, as did girls, and younger individuals.
There was a significant gender effect on SSRT across all
levels of ADHD traits at age 6, with the largest difference
(36 ms) seen at an ADHD trait score of 54 (Table 2). This
difference corresponded to an effect size of 0.34. There was
no significant gender effect at age 18. The effect of ADHD
trait score on SSRT was seen across each age and gender
group, with the highest difference observed in females at
age 6, where the difference of 138 ms seen between the
predicted SSRT at a low ADHD trait score of −54 and a high
ADHD trait score of 54 corresponded to an effect size of
1.48.
Gender (p<0.0001), ADHD traits (p<0.0001), age (p<
0.0001), age*age (p<0.0001), age*gender (p<0.0001) and
age*age*gender (p00.0005) were significantly associated
with GoRT. On average, boys, older children and those with
lower ADHD trait scores had faster response latencies.
ADHD traits (p<0.0001), gender (p<0.0001), age (p<
0.0001), age*age (p<0.0001) and age*gender (p<0.0001)
significantly predicted GoRTSD. Models of GoRTSD that
included GoRT did not change estimates of these effects. On
average, individuals with lower ADHD trait scores, boys
and older individuals were less variable than girls, younger
participants and those with more ADHD traits. The largest
difference in GoRT between the lowest and highest ADHD
trait score of 30 ms (ES00.35) was seen among females at
age 6; however, differences were similar across other gen-
ders and age combinations. The difference of 51 ms seen on
the GoRTSD between an ADHD trait score of −54 and 54
for females at age 6 corresponded to an effect size of 1.4. As
with SSRT, the gender effects for GoRT and GoRTSD were
greater at age 6 with a difference of 43 ms (ES00.50) on the
GoRT and a difference of 21 ms (ES00.60) on the GoRTSD
(Table 2). There was no significant gender effect at age 18
on either measures.
Models that included ADHD traits*ADHD traits, age*-
age and age*age*gender did not significantly improve pre-
diction of SSRT, GoRT or GoRTSD. Inspection of plots
indicated that the relationship of Swan ADHD trait scores
and each of the stop task variables did not vary perceptibly
Table 1 Characteristics (mean or %) of study sample (N014,388) and
excluded cases (N01,710)
Variable Study sample
(n014,388)
Excluded cases
(n01,711a)
Significance
of group
differenceMean (SD) Mean (SD)
ADHD traits −5.8b (16.3) 3.2 (18.9) <0.0001
Age 11.2 (2.8) 10.1 (2.8) <0.0001
Male 49.9 57.2 <0.0001
ADHD 3.7 26.8 <0.0001
Caucasians 51.3 52.0 0.50
a 1711 participants had taken medication within 2 days of participation
in the study (414) or had invalid or incomplete performance on the SST
(1297) as defined in the Method section
b ADHD traits (SWAN scores) where higher scores indicate greater
severity of ADHD traits (see text for details)
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across different levels of the Swan. ADHD inattention and
ADHD hyperactivity-impulsivity were related to SSRT,
GoRT and GoRTSD in the same way as ADHD trait total
scores.
Heritability Estimates for Stop Signal Task Variables
Univariate heritability (estimates, confidence intervals) ad-
justed for age and sex were significant for SSRT [h200.31
(0.03), p06.3×10−23], GoRT [h200.26 (0.03), p<9.71×
10−16] and GoRTSD [h200.28 (0.03), p<3.9×10−17]. Total
ADHD trait scores [h200.38 (0.03), p<2.7×10−36],
hyperactivity-impulsivity [h200.4 (0.03), p<4.7×10−40]
and inattention [h200.24 (0.03), p<3.4×10−15] were also
heritable. Age and sex accounted for differing proportions
of phenotypic variance, but had little effect on estimates of
heritability. Exclusion of ADHD trait scores in the herita-
bility estimates had no impact on heritability estimates.
Table 3 shows bivariate heritability estimates for ADHD
traits, SSRT, GoRT and GoRTSD adjusted for age and sex.
ADHD traits and SSRT showed significant genetic correla-
tion (0.18), indicating modest shared genetic risk for greater
ADHD traits and longer SSRT. ADHD traits and GoRT and
GoRTSD did not show significant bivariate heritability.
Inattention and hyperactivity-impulsivity had a genetic cor-
relation of 1 indicating complete pleiotropy. There was a
significant genetic correlation of SSRT and inattentive
(0.23) and of SSRT and hyperactive-impulsive (0.14) traits.
Hyperactivity-impulsivity, but not inattention scores were
genetically correlated with GoRT (−0.19). There was evi-
dence of substantial co-heritability of GoRT and GoRTSD
(0.71) and for SSRT and GoRTSD (0.42), but not SSRT and
GoRT (−0.11). Inclusion of cases who reported taking med-
ication for ADHD within 48 h of participation did not alter
substantially the results of the analyses.
Discussion
In the largest general population study reported to date we
found support for the validity of response inhibition as an
endophenotype of ADHD. Response inhibition, latency and
variability were significantly correlated with ADHD traits
even after controlling for age and gender. Analysis of the
family data indicated that inhibition, latency and variability
were heritable; however, of these three measures only inhi-
bition shared genetic risk with ADHD traits. Current results
have implications for understanding the genetic contribu-
tions to ADHD traits and to higher-order executive func-
tions as well as for the design of genetic studies.
Participants with greater ADHD traits had longer SSRTs
indicating inferior inhibition, slower response latencies and
greater response variability than did those with fewer
ADHD traits. The relationship of ADHD traits and inhibi-
tion was strong. Participants with highest ADHD trait scores
had SSRTs that were substantially slower indicating less
Fig. 1 Scatterplot of response inhibition (SSRT; interpolated and plotted on log scale) and ADHD traits (SWAN scores) for entire sample of 14,388
participants of all ages and both sexes
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efficient inhibition than among those with the lowest trait
scores across age and sex. The magnitude of these differ-
ences was substantial for both girls (e.g., age 6; 138 ms,
ES01.48) and boys (e.g., age 6; 129 ms, ES01.48). These
effects are comparable to those found in a meta-analysis of
studies comparing ADHD clinic cases and healthy controls
(Lipszyc and Schachar 2010). In that review, ADHD cases
had a mean SSRT of 330 ms and controls had a mean score
of 254 ms. Participants in those studies were approximately
10–12 years of age. Estimates of SSRT in the current data
for children of that age were 329 ms for those with greatest
ADHD traits scores and 231 ms for those with lowest
ADHD trait scores. These converging data provide consid-
erable support for the current results. We conclude that this
general population sample included individuals at the
extremes of ADHD trait and SST performance distributions
that are equivalent to cases and controls typical of clinic-
based case–control studies. Indeed, we found that 6.3 % of
Fig. 2 Distribution of ADHD traits in general population sample. Note: ADHD traits were measured using the SWAN. The SWAN scores were
reversed such that higher ADHD traits were represented by higher SWAN scores
Table 2 Stop task values (95%ile
confidence intervals) estimated
from themodel, by gender, ADHD
trait score and age extremes
SSRT stop signal reaction time;
GoRT mean response latency;
GoRTSD response variability
aNegative values of the ADHD
trait indicate lower ADHD trait
values and positive values indi-
cate higher ADHD trait values
ADHD Traita
Female Male
Age 6 Age 18 Age 6 Age 18
SSRT Lowest (−54) 398 (385; 412) 177 (170; 183) 371 (359; 384) 177 (170; 185)
Highest (54) 536 (516; 557) 238 (229; 247) 500 (483; 518) 239 (228; 249)
GoRT Lowest (−54) 735 (723; 747) 521 (512; 530) 693 (682; 705) 528 (517; 539)
Highest (54) 765 (752; 779) 542 (532; 552) 722 (710; 734) 549 (537; 561)
GoRTSD Lowest (−54) 205 (200; 210) 118 (115; 121) 188 (183; 193) 119 (115; 122)
Highest (54) 256 (249; 264) 147 (143; 152) 235 (229; 241) 148 (143; 153)
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all participants self-reported a diagnosis of or treatment for
ADHD supporting the conclusion that the sample was quite
representative of the general population. Participants with
high ADHD trait scores were substantially more variable
than those with low ADHD trait scores with effect sizes that
are comparable to those observed for response time variabil-
ity in previous studies (Frazier-Wood et al. 2012). There was
far less of a difference in response latency between those
with high and those with low ADHD trait scores. We also
note that the relationship of ADHD traits and each cognitive
measure was consistent across the entire distribution of
ADHD indicating that associations were essentially linear
and not driven by those at the extremes of the ADHD trait.
Univariate heritability estimates were significant for
SSRT, GoRT, and GoRTSD. The moderate magnitudes of
these heritability estimates (from 0.26 to 0.31) are compa-
rable to heritability estimates from prior studies of executive
functions, specifically those on SSRT (Andreou et al. 2007;
Frazier-Wood et al. 2012; Friedman et al. 2008; Kuntsi et al.
2010; Schachar et al. 2011). Moreover, SSRT, GoRT and
GoRTSD were heritable even with adjustment for the well-
documented effect of ADHD traits on these parameters
indicating that heritability of cognitive traits are similar
across the range of ADHD traits. We interpret the observed
interfamilial correlation as indicative of genetic effects be-
cause previous twin studies show that familial influences on
ADHD traits (Faraone and Doyle 2000) and on SST param-
eters (Schachar et al. 2011) are largely due to genetic effects
with minimal influence of shared environment.
There was evidence of shared genetic risk between poor
response inhibition (longer SSRT) and high ADHD trait
scores whereas there was little evidence for shared genetic
risk for ADHD traits and either response latency (GoRT) or
variability (GoRTSD) (c.f. Kuntsi et al. 2010; Frazier-Wood et
al. 2012). Shared genetic risk implies the potential for com-
mon genetic contributors. The significant although modest
phenotypic and genetic correlation of SSRTand SWAN scores
indicates that the ADHD phenotype is complex and is likely to
be the final common outcome of multiple biological pathways
only some of which involve deficient motor response inhibi-
tion. Significant genetic correlation indicates that genetic fac-
tors influence the extent to which these traits overlap.
However, significant genetic correlation does not prove that
a purported endophenotype has a simpler genetic architecture.
Ultimately, the utility of an endophenotype will be proven in
gene discovery. The role of this paper was to assess the
potentially utility of response inhibition, latency and variabil-
ity as measured in the SST as candidate endophenotypes.
The results of the current study are consistent with pre-
vious research on the link between ADHD and deficient
response inhibition, latency and variability in clinical sam-
ples. Current results also confirm the findings of the two
studies that have been conducted in the general population;
Cornish et al. (2005) in an unselected general population
sample studied with a different measure of inhibition and
Friedman et al. (2008) in a twin sample studied with the
SST. In the later sample as in the current study, there was
evidence of shared genetic risk between a composite mea-
sure of inhibitory control and impulsiveness (Young et al.
2009).
Older participants exhibited better response inhibition
than did younger participants as has been found in most
(Williams et al. 1999) but not all (Friedman et al. 2008;
Young et al. 2009) studies of inhibition and other executive
functions. Older participants were also faster and less vari-
able. Males were significantly although minimally better
inhibitors and were faster and less variable in their responses
than were girls, but the male advantage was not evident in
older participants. There was no interaction between gender
and ADHD trait scores indicating that gender effects were
similar for those with high and low ADHD traits. Neither
ethnicity nor socioeconomic status affected SST perfor-
mance significantly. Consistent with prevalence rates for
the disorder, ADHD traits were more marked among males.
In contrast to the supposed increase prevalence of inattentive
subtype of ADHD in females, we found that males had higher
scores for both inattention and hyperactivity-impulsivity as
measured by the SWAN.
Table 3 Results of bivariate heritability analyses: genetic correlations (standard errors) among neurocognitive measuresa
Rhogb (S.E) ADHD trait ADHD_IA ADHD_HI SSRT GoRT GoRTSD
SSRT 0.18 (0.07)c 0.23 (0.08)c 0.14 (0.07)c 1 −0.11 (0.08) 0.42 (0.08)c
GoRT −0.12 (0.07) −0.04 (0.09) −0.19 (0.07)c 1 0.71 (0.05)c
GoRTSD 0.05 (0.07) 0.09 (0.09) 0.02 (0.07) 1
SSRT stop signal reaction time; GoRT mean response latency; GoRTSD response variability; ADHD_IA SWAN inattentive subscore; ADHD_HI
SWAN hyperactive-impulsive subscore
a all SOLAR models include age, sex, and ethnicity as covariates
b Evidence of pleiotropy is indicated by a genetic correlation significantly different from zero (Rhog00: no shared gene effect; Rhog01 or −1:
complete pleiotropy)
c significant p-value tests indicating genetic correlation
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In contrast to the results of twin studies, age had no signif-
icant effect on heritability of the cognitive measures studied
here (c.f. Friedman et al. 2008). The heritability of ADHD traits
as measured by the SWAN is comparable to some (Hay et al.
2007) but not other (Polderman et al. 2007) twin studies and is
lower than typically reported using other measures of ADHD.
Hay et al. (2007) speculated that the increased rating options
available in the SWAN afford a greater opportunity than other
rating scales for informants to rate their siblings as similar.
The study revealed details of heritabilities of ADHD sub-
components. Both inattention and hyperactivity-impulsivity
were associated with inhibition, latency and variability. Both
dimensions were heritable even after controlling for age and
sex and the two trait dimensions shared substantial genetic
risk as has been found in previous twin studies (Hay et al.
2007; Polderman et al. 2007; Swanson et al. 2001). Both
dimensions share genetic risk with response inhibition. The
genetic risks that are shared by hyperactivity-impulsivity and
response latency seem to increase the behavioral trait and
decrease response latency.
One limitation of evaluating executive function in the
general population is that many participants took medication
for ADHD within 48 h of participation in the study. On one
hand, these observations support the conclusion that the
community sample was typical of the population thereby
enhancing the generality of our observations and conclu-
sions. On the other hand, stimulants are known to improve
response inhibition (Tannock et al. 1995) raising the possi-
bility that our data could be censored at the high end of the
distribution. The problem of studying disorders in the gen-
eral population with a substantial proportion under treatment
for the disorder of interest is common to many disorders
(Tobin et al. 2005). The effect of therapy in epidemiological
studies could distort trait scores causing reduction in the
estimated effect of etiological determinants and a marked
loss in statistical power. Various strategies have been used to
correct for this effect such as exclusion of treated individuals
and use of treatment as a covariate. We addressed this
potential confound with what is thought to be the optimal
strategy, namely by estimating the effect of stimulant treat-
ment on inhibition from a prior study in order to introduce a
correction among medicated individuals, thereby reducing
the bias arising from treatment or from their exclusion (Rice
et al. 2009; Tobin et al. 2005). We applied this correction for
medication effect to the scores of the 414 medicated partic-
ipants based on published studies that showed a 0.75 effect
size effect of stimulant medication (Tannock et al. 1995).
Multivariate model parameters and heritability estimates
were unaltered when models were rerun following this
correction. This type of correction allows for the inclusion
of treated participants in genetic studies.
Although study of individuals in the general population is
a powerful strategy for the cost-effective collection of
samples for cognitive and genetic research, it is important
to note that it is far more difficult to collect data on multiple
cognitive measures in this setting. Friedman et al. (2008) has
argued that combining multiple cognitive measures into a
latent factor can increase the heritability of clusters of exec-
utive control measures by minimizing the effect of variance
not attributable to the particular executive control construct.
They argued that latent factor scores might be even more
powerful in genetic studies than any single measure.
Another limitation of using cognitive tasks to measure
ADHD endophenotypes is evident in the participants who
had to be excluded because of invalid stop task perfor-
mance. Many of these participants had invalid performance
because of administration errors such as pushing the wrong
buttons on the game pad device used to collect responses or
leaving the task before it was complete because their family
wished to continue their visit to the Science Centre. These
errors may have been minimized through more intensive
participant supervision, although it is unlikely that they
can be eliminated totally in a busy general population set-
ting. However, a portion of invalid stop task data is non-
random. Individuals with invalid performance had signifi-
cantly higher ADHD trait scores suggesting a systematic
bias, which would serve to exclude those participants of
greatest interest. These participants were also younger and
more likely to be males. Given knowledge of participants’
age, gender and ADHD trait scores, it would be possible to
estimate their performance using a regression model. Al-
though the distribution of household income among Science
Centre visitors was skewed toward higher incomes com-
pared to the surrounding community, social class did not
make a significant contribution to models of inhibition,
latency, or variability or to ADHD traits.
The current results support the strategy of using endo-
phenotypes in a general population for selection of individ-
uals at high and low genetic risk for ADHD for genetic
study. The “extreme trait” (also known as “selective geno-
typing”) approach using endophenotypes is a particularly
powerful and cost-effective design for detecting genetic
association (Huang and Lin 2007; Van Gestel et al. 2000).
The approach has been successful in studies of QT interval
(Arking et al. 2006), obesity (Herbert et al. 2006), foetal
haemoglobin level (Menzel and Thein 2009), and in one
previous candidate gene study for ADHD traits (Cornish et
al. 2005). Another advantage of this approach is increased
ease of collection due to the ready availability of general
population samples compared to clinically ascertained sub-
jects. We estimated that the cost of accruing participants
from the general population was 10 % of the per subject
cost in clinic samples.
Based on the current results and on previously published
research, we conclude that inhibition is a heritable trait
which is sensitive to variation across the range of ADHD
J Abnorm Child Psychol (2013) 41:497–507 505
traits and shares genetic risk with ADHD traits. Identifica-
tion of genes involved in risk for inhibition may be a
powerful way to identify ADHD related genetic risks.
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